Japan Health Ministry says it has approved Pfizer's COVID-19 vaccine

FILE PHOTO: Vials labelled "COVID-19 Coronavirus Vaccine" and sryinge are seen in front of displayed Pfizer logo in this illustration taken, February 9, 2021. REUTERS/Dado Ruvic/Illustration/File Photo
News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
TOKYO (Reuters) - Japan's Health Ministry said on Sunday it has officially approved Pfizer Inc's COVID-19 vaccine, the first such approval in the country as it steps up efforts to tame a third wave of infections in the run-up to the Summer Olympic Games.
The move had been widely expected after a government panel recommended approval on Friday, at which point Health Minister Norihisa Tamura said Japan would give its final approval as soon as possible.
Prime Minister Yoshihide Suga has said vaccinations will begin from the middle of next week, starting with some 10,000 health workers. The government hopes to secure enough supplies for the whole populace - some 126 million people - by mid-year.
Much of Japan is still under a state of emergency after its third and most deadly wave of the virus hit late last year. Cases and fatalities have trended lower in the past couple of weeks and Tokyo logged just under 400 cases in the capital on Sunday.
Japan has so far recorded about 410,000 coronavirus cases nationally and 6,772 deaths. The Olympic Games are due to start July 23.
(Reporting by Kiyoshi Takenaka and Elaine Lies; Editing by Kenneth Maxwell)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Prince Philip's islander devotees inspired by shared respect for tradition
- Iran orders 10-day shutdown amid 4th wave of coronavirus pandemic
- Two killed during anti-U.N. protests in eastern Congo protests, officials say
Create E-mail Alert Related Categories
ReutersSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!